Researchers at the Massachusetts Institute of Technology (MIT) have innovatively employed artificial intelligence to design novel antibiotics that potently tackle two particularly challenging infections: drug-resistant Neisseria gonorrhoeae and methicillin-resistant Staphylococcus aureus (MRSA).
